Functional eicosanoid test and typing (FET) of peripheral blood cells in eicosanoid related diseases

Journal of Physiology and Pharmacology

Volumn 56, Issue SUPPL. 5, 2005, Pages 103-118

  Schafer D ^a   Baenkler, H W ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Eicosanoid pattern; FET; Functional Eicosanoid Typing; in vitro test; Inflammatory diseases

Indexed keywords

LEUKOTRIENE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2;

ADULT; AGED; ARTICLE; ASTHMA; BIOLOGICAL MODEL; BLOOD; BLOOD CELL; CALIBRATION; CASE CONTROL STUDY; FEMALE; GASTROINTESTINAL TUMOR; HUMAN; IN VITRO STUDY; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; STOMACH ULCER; TIME;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASTHMA; BLOOD CELLS; CALIBRATION; CASE-CONTROL STUDIES; DINOPROSTONE; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; LEUKOTRIENES; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; STOMACH ULCER; TIME FACTORS;

EID: 34147092646     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (34)

1. Abraham WM. The interaction among granulocyte lipid mediators and the generation of oxygen radicals in antigen-induced airway hyperresponsiveness. Adv Prostaglandin Thromboxane Leukot Res. 1994;22:131-140
2. Abrishami MA & Thioma J. Aspirin intoleramce a review. Ann Allerg 1977; 39: 28.37.
3. Baenkler HW, Schäfer D, Hosemann W. Eicoanoid pattern in nasal polyps and nasal mucosa. Rhinology 1996; 34: 166-170.
4. Baenkler HW, Zeus J, Schenk J, Schäfer D. Abnormal eicosanoid pattern by blood leukocytes in gastroduodenal ulcer. Medical Science Monitor, 2004;10: CR447-556.
5. Bergström B. Prostaglandines: Members of a new hormonal system. Science 1967; 157: 323-390.
6. Chung KF. Leukotriene receptor anatagonists and biosynthesis inhibitors: potential breakthrough in asthma therapy. Eur Respir J 1985; 8: 1203-1213.
7. Cohn LA, Adler KB. Interactions between airway epithelium and mediators of inflammation. Exp Lung Res. 1992; 18(3): 299-322.
8. Gosepath J, Hoffmann F, Schäfer D, Amedee RG, Mann WJ. Aspirin Intolerance in patients with chronic sinusitis. ORL 1999; 61: 146-150. (Pubitemid 29213648)
9. Gosepath J, Schäfer D, Amedee RG, Mann WJ. Individual monitoring of aspirin desensitization. Arch Otolaryngol Head Neck Surg 2001; 127: 316-321.
10. Gosepath J, Schäfer D, Mann WJ. Analgetika-Intoleranz: Langzeitergebnisse bis zu 3 Jahren be adaptativer Desaktivierung mit einer täglichen Erhaltungsdosis von 100 mg Aspirin. Laryngo- Rhino-Otol 2002; 81: 732-738. (Pubitemid 35350952)
11. Gosepath J, Brieger J, Gletsou E, Mann WJ. Expression an dlocalisation of cyclooxygenases (Cox-1 AND Cox-2 in nasal respiratory mucosa. Does Cox-2 play a key role in the immunology of nasal ployps? J Invest allergol Clin Immunol 2004; 14: 114-118. (Pubitemid 38987682)
12. Ham ED, Sodermann DD, Zanetti ME, Doughgerry HW, McCauley E, Kuehl FA. Inhibition by prostaglandins of leukotriene B4 release from activatedc neutrophils. Proc Natl Acad Sci USA 1993; 80: 4349-11353
13. Hecksteden K, Schäfer D, Stuck BA, Klimek L, Hörmann K. Diagnosk des Analgetika- Intoleranz-Syndroms mittels funktioneller Zelltestung (analgetika-Intoleranz-Test: AIT). Allergologie 2003; 26: 263-271. (Pubitemid 36917238)
14. Holtzman MJ, Pentland A, Baenziger NL, Hansbrough JR. Heterogeneity of cellular expression of arachidonate 15-lipoxygenase: implications for biological activity. Biochim Biophys Acta. 1989;1003(2): 204-208. (Pubitemid 19145437)
15. Juergens UR, Christiansen SC, Stevenson DD, Zuraw BL. Arachidonic acid metabolism in monocytes of aspirin-sensitive sthmatic patients before and after oral aspirin challenge. Allergy Clin Immunol 1992; 90: 636-645.
16. Kaldenbach T, Schäfer D, Gosepath J, Bittinger F, Klimek L, Mann WJ. Die Bedeutung eosinophiler Granulocyten in Beziehung zu Allergie und Aspirin-Intoleranz bei Patienten mit Sinusitis polyposa. Laryngo Rhino Otol 1999; 78: 429-434. (Pubitemid 29411189)
17. Kloprogge E, Leeuw AJ, Monchy JGR, Kaufma HF. Cellular communication in leukotriene C4 production between eosinophils and neutrophils. J Allergy Clin Immunol 1989; 83: 393-400.
18. Kurosava M, Yodonuwa S, Tsakagoshi H. Inhibition of bronchial hyperresponsiveness to histamine induced by intravenous administration of leukotriene C4 by novel thromboxane A2 receptor antagonists ONO-NT-126 and ONO-8809 inn guinea pigs. Clin Exp Allergy 1993; 23: 843-850. (Pubitemid 23327379)
19. Larssen JS, Acista EP. Leukotreine-receptor antagonists and 5-lipoxygenase inhibitors in asthma. AnnPharmacotherapy 1993; 27: 898 903.
20. Lauriston K, Laursen LS, Bukhave K, Rachmilewitz D. Effects of systemic prednisolone and arachidonic acid metabilites determined by equilibrium in vivo dialysis of rectum in severe relapsing ulcerative colitis. Gastroenterology 1985; 88: 1466.
21. Marcus AJ. Eicosanoids: transcellular metabolism. In Inflammation: Basic principles and clinical correlates, Gallin JI, Goldstein IM, Snyderman T (eds.), New York, Raven Press, 1988: 129-137.
22. Morlion BJ, Torwesten E, Kuhn K, Puchstein C, Fürst P. Cysteinyl-leukotriene generation as biomarker for survival in the critically ill. Crit Care Med 2000; 28: 3655-3658. (Pubitemid 30949006)
23. Pavord ID, Tattersfield AE. Bronchoprotective role for endogenous prostaglandin E2. Lancent 1995; 345: 436-438.
24. Phipps RP. A new view of prostaglandin E regulation of the immune response. Immunolgy Ttoday 1991; 12: 351-352.
25. Pompeia C, Procopio J, Curi R. Fatty acids and immune systm. Barzilian Journal of Phramaceutical Sciences 1999; 35: 166-194.
26. Rampton DS, Sladen GE, Youlton LY. Rectal mucosal prostaglandin E2 release and its relation to disease activitity; electrical potential differences and treatment in ulcerative colitis. Gut 1980; 21: 591-596.
27. Reinecker HC, Schreiber S, Stenson WF, Mac Dermott RP. The role of the mucosal immune system in ulcerative colitis and Crohn's disease, In Handbook of mucosal immunology, Ogra PL, Lamm ME, McGhee JR, Mestecky J, Strober W, Bienstock J (eds), Academic Press, San Dieago, 1994: 439-456.
28. Samuelsson B, Dahlen SE, Lindgren JA, Rouzer CA, Serhan CN. Leukotrienes amd lipxins: structures, biosynthesis, and biological effects. Scince 1987; 237: 1171-1176. (Pubitemid 17131222)
29. Schäfer D, Lindenthal U, Wagner M, Bölcskei PL, Baenkler HW. Effect of prostaglandin E2 on eicosanoid release by human bronchial biopsy specimens from normal and inflamed mucosa. Thorax 1996; 51: 919-932.
30. Schäfer D, Schmid M, Göde U, Baenkler HW. Dynamics of eicosanoids in peripheral blood cells during bronchial provication in aspirin-intolerant asthmatics. Eur Respir J, 1999; 13: 638-646. (Pubitemid 29180179)
31. Schmid M, Göde U, Schäfer D, Wiegand ME. Arachidonic acid metabolism in nasal tissue and peripheral blood cells in aspirin intolerant asthmatics. Act Otholaryngol (Stockh) 1999; 199: 277-280. (Pubitemid 29177083)
32. Sharon P, Ligumsky M, Rachmilewitz D, Zor U. Role of prostaglandin in ulcerative colitis - enhanced production during active disease and inhibition by sulfsalacine. Gastroenterology 1978; 75: 638-640. (Pubitemid 9025499)
33. Smith WL. The eicosanoids and their biochemical mechanisms of action. Biochem J 1989; 259: 315-324. (Pubitemid 19111664)
34. Szczeklik A. Prostaglandin E2 and aspirin-induced asthma. Lancet 1995; 345: 1056.